.avia-section.av-k5b5yvsi-20bebd3cddc81d1158c1f6e4b3ef0d2a .av-parallax .av-parallax-inner{
background-repeat:no-repeat;
background-image:url(https://medi-paper.com/wp-content/uploads/2020/01/ADDING-RIBOCICLIB-TO-FULVESTRANT-IMPROVES-THE-SURVIVAL-OF-ADVANCED-BREAST-CANCER-PATIENTS-MONALEESA-3.jpg);
background-position:50% 0%;
background-attachment:scroll;
}

.flex_column.av-de5bsit-05e93e3a896a1f2c350d9d4da1a68a08{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .av-special-heading.av-prk64l-fcac263face01f81c5ab5b64bbbca942{
padding-bottom:10px;
}
body .av-special-heading.av-prk64l-fcac263face01f81c5ab5b64bbbca942 .av-special-heading-tag .heading-char{
font-size:25px;
}
.av-special-heading.av-prk64l-fcac263face01f81c5ab5b64bbbca942 .av-subheading{
font-size:15px;
}

.flex_column.av-18a2xut-2efe8d6629823fdc44b54d4530d9ddca{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .av-special-heading.av-k5b5soyx-337b33dac1d88210ce8941ff499f53a3{
padding-bottom:10px;
}
body .av-special-heading.av-k5b5soyx-337b33dac1d88210ce8941ff499f53a3 .av-special-heading-tag .heading-char{
font-size:25px;
}
.av-special-heading.av-k5b5soyx-337b33dac1d88210ce8941ff499f53a3 .av-subheading{
font-size:15px;
}

.flex_column.av-bchrorp-7ca1e81d6f067a42fd681318e0ff8449{
border-width:2px;
border-color:#999999;
border-style:solid;
border-radius:6px 6px 6px 6px;
padding:2% 2% 2% 2%;
background-color:#ffffff;
}

.flex_column.av-ajaxm1x-659c71289f6ae4d0968c1c50c0d2355d{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .hr.hr-invisible.av-9wnv6w5-85326267cdde5fe937ad01c1a93a15b5{
height:30px;
}

#top .hr.hr-invisible.av-9btvg5h-9b27b7d24b282da3efcf317a4ea53190{
height:30px;
}

#top .hr.hr-invisible.av-8vtsf7p-880664d56980662a49f87d1456a55b47{
height:30px;
}

#top .hr.hr-invisible.av-8ighls5-5a5ff344da6e54a596e0caa624ef78dd{
height:30px;
}

#top .hr.hr-invisible.av-7xuexdx-3db12e2495f42b9824ca849eb6e4903c{
height:30px;
}

#top .av_textblock_section.av-k5b6dh60-681f9781292980e2a55035719420a392 .avia_textblock{
font-size:10px;
}

.flex_column.av-3clbeit-3e3e340e8a1910e111069651b3fcecbf{
border-width:2px;
border-color:#cccccc;
border-style:solid;
border-radius:6px 6px 6px 6px;
padding:2% 2% 2% 2%;
}

#top .hr.hr-invisible.av-1aci4h1-1643c559a1ba7cca363ebee1f20b1dc4{
height:30px;
}

#top .hr.hr-invisible.av-4ube15x-cdbc96ff4e2ae16274b311a03f27abc2{
height:30px;
}

.flex_column.av-49z0pxh-9074db54bb839f90d1807c70de4eaa01{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .av_textblock_section.av-3raym9x-406a217fab6488ce20e41d9f734258d7 .avia_textblock{
font-size:10px;
}

#top .hr.hr-invisible.av-3fpym6d-43dba51b53fc04b3b754441c3be27012{
height:30px;
}

#top .hr.hr-invisible.av-2p6mgw5-52df9776edee5811ad9a34e84f191f16{
height:30px;
}